Clinical Trial Update: Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating a regimen of bortezomib, melphalan, and total-body irradiation before stem cell transplantation in patients with multiple myeloma has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Alkeran (melphalan)
• Velcade (bortezomib)

Snippet

Sponsor: Mayo Clinic | Conditions: DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma | Phase 1 | Status: COMPLETED